DIA
Drug Information Association Logo

THE CASE FOR AND AGAINST A REFORM OF THE PHARMACEUTICAL LEGISLATION

Track:
Hot Topics/Stand Alone

Day & Time:
March 26, 4:00PM - 5:30PM (Central European Standard Time)

Session Number:
1704

Room Number:
Room H

Type:
Session

Title:
THE CASE FOR AND AGAINST A REFORM OF THE PHARMACEUTICAL LEGISLATION

Chair(s):
David B. Jefferys, MD, FRCPC
Senior Vice President
EFPIA, Elsai Europe Limited, United Kingdom

Description:
THE CASE FOR AND AGAINST A REFORM OF THE PHARMACEUTICAL LEGISLATION

Presentation(s) & Speaker(s):
Update on Review of The Escher Project and Emerging Findings
Jean Philippe de Jong, DrMed, MD, PhD, MA, MSc
Project Leader, Exon Consultancy
The Escher Project, Netherlands

Views on Conditional Authorisation - what is possible now and what could be developed within the existing legislation
Christiana Rothkegel
Regulatory Program Manager
F. Hoffmann-La Roche, Switzerland

Meeting the Challenges of Safety Referrals and Hope for the Future
Sarah Montagne
Head of EU Regulatory Policy
Bayer Plc, United Kingdom